Lehrstuhl für Haut- und Geschlechtskrankheiten

Effectiveness of Tildrakizumab in the Long-Term Treatment of Plaque Psoriasis: A Retrospective, Multicenter Analysis Over 76 Weeks (2025) Glatzel C, Fleißner J, Shuti T, Glatzel V, Dege T, Schmieder A, Goebeler M, et al. Journal article Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1 (2025) Heger L, Berking C, Hackstein H Journal article Trichophyton mentagrophytes ITS Genotyp VIII/Trichophyton indotineae in Deutschland – Neubewertung nach 5 Jahren (2025) Uhrlaß S, Panzer R, Koch D, Mütze H, Richter S, Müller L, Ardabili M, et al. Journal article Hazard rates and implications for follow-up schedules of melanoma patients with 0.8–1.0 mm tumor thickness: An analysis of the German Central Malignant Melanoma Registry in 12,132 patients (2025) Aebischer V, Nanz L, Amaral T, Berking C, Eigentler T, Flatz L, Forschner A, et al. Journal article Multiple squamous cell carcinomas arising in linear porokeratosis Multiple Plattenepithelkarzinome auf einer linearen Porokeratose (2025) Busch D, Berking C, Schliep S, Erfurt-Berge C Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp. (2025) Reinhold U, Philipp-Dormston WG, Dirschka T, Ostendorf R, Aschoff R, Berking C, Jäger A, et al. Journal article Corrigendum: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index (Frontiers in Medicine, (2025), 12, (1574413), 10.3389/fmed.2025.1574413) (2025) Kemenes S, Chang L, Schlereth M, Corte G, Noversa de Sousa R, Minopoulou I, Fenzl P, et al. Journal article, Erratum Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on dendritic cell and natural killer cell subsets after renal transplantation (2025) Weber S, Wei X, Chen G, Yankouskaya K, Yin D, Allabauer I, Jobst-Schwan T, et al. Journal article